Form 4 for BSX Boston Scientific
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0001225208-25-008843 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-31 | 2025-10-29+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +12.2K | 363.7K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-29 | G | A | 88,197 | $0.00 | 289,675 | I By Trust | — | — | |
| 2 | Common | Common Stock | 2025-10-30 | G | D | 149,992 | $0.00 | 213,679 | I By Trust | — | — | |
| 3 | Common | Common Stock | 2025-10-29 | G | A | 73,996 | $0.00 | 363,671 | I By Trust | — | — |